Physician profile
Sandy Marcus
NPI 1316510324
$2,235.61
in general payments reported to CMS, 2019-2025
17 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Psychiatric/Mental Health (Registered Nurse) provider received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.77 · 2022: $120 · 2023: $790 · 2024: $962 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,096 · Education: $6.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.23 |
| Education | $6.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $607.22 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Vanda Pharmaceuticals INC. | $341.66 | 2024-2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $222.97 | 2023-2024 | Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $194.02 | 2023-2025 | Aristada, Aristada Initio, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $188.79 | 2023-2025 | Austedo Xr, Austedo Xr |
| Supernus Pharmaceuticals, INC. | $158.56 | 2023-2024 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $150.03 | 2023-2025 | Caplyta |
| Ironshore Pharmaceuticals INC. | $114.95 | 2023 | Jornay Pm |
| Corium, LLC | $105.13 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $31.47 | 2025 | Cobenfy |
| Glaxosmithkline, LLC. | $28.07 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $23.55 | 2025 | Capvaxive, Enflonsia, Gardasil 9 |
| Lilly USA, LLC | $15.07 | 2022 | |
| Novo Nordisk INC | $14.57 | 2024 | Ozempic, Rybelsus |
| Vertex Pharmaceuticals Incorporated | $14.07 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $12.77 | 2021 | |
| Abbvie INC. | $12.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.